BioSpace News Archive

Agilis Robotics, an innovative spin-off company from The University of Hong Kong, is making waves in the realm of endoscopic surgery with its flexible robotic arms.

Bridge Biotherapeutics presented a poster with preclinical data updates of its drug candidate BBT-207 at the American Association for Cancer Research 2023 annual meeting, being held from April 14 to 19 in Orlando, Florida.

Nona Biosciences announced it has entered into a collaboration agreement with Michael S. Diamond, MD, PhD, of Washington University in St. Louis to discover viral targets for which few or no human monoclonal antibodies currently exist, such as western equine encephalitis virus, rabies and severe fever with thrombocytopenia syndrome virus.

EMulate Therapeutics announced that Chris Rivera will present an overview of current results and future plans for EMTx at the Life Science Innovation Northwest 2023.

The Insight Partners published latest research report on “Cell Line Development Market Share Report, Size, Analysis, Statistics, Trends & Forecast to 2027 - COVID-19 Impact and Global Analysis by Type, Product, Application and Geography,”

Life Spine announced that the Company has published a new retrospective study examining the effect of expandable versus static interbody implants via the Journal of Spine Surgery.

Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (‘Awakn’), a biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD)

GE HealthCare is further advancing its precision care strategy with CT-Navigation, which offers clinicians detailed, real-time, 3D computed tomography images for stereotactic needle guidance across an array of care areas, including interventional and oncological procedures as well as biopsies, ablations, drainage, therapeutics and more.

Neurotech Solutions continues to revolutionize attentional analytics with MOXOedu, a cloud-based tool that has been calibrated for assessing and profiling human attention

Sutro Biopharma, Inc. today announced expanded preclinical data for STRO-003, its ROR1 targeting ADC, presented at the American Association for Cancer Research (AACR) Annual Meeting 2023, being held in Orlando, Florida from April 14-19, 2023.